The use of milrinone in a patient with mitral regurgitation and severe pulmonary hypertension: A case report

Japanese Journal of Anesthesiology

Volumn 52, Issue 7, 2003, Pages 762-765

  Yamada, Tatsuya ^a   Katori, Nobuyuki ^a   Tagawa, Manabu ^a   Yamamoto, Shinichi ^a   Arisaka, Hiroshi ^a   Takeda, Junzo ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Milrinone; Mitral regurgitation; Pulmonary hypertension

Indexed keywords

MILRINONE; PHOSPHODIESTERASE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; CLINICAL TRIAL; FEMALE; HEART OUTPUT; HEART SURGERY; HUMAN; INOTROPISM; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; PULMONARY HYPERTENSION; VASODILATATION;

AGED; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MILRINONE; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; PHOSPHODIESTERASE INHIBITORS;

EID: 0041311129     PISSN: 00214892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Curran RD, Mavroudis C, Backer CL, Sautel M, Zales VR, Wessel DL. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension. Ann Thorac Surg 1995; 60: 1765-71.
2. Skoyles JR, Sherry KM. Pharmacology, mechanisms of action and uses of selective phosphodiesterase inhibitors. Br J Anaesth 1992; 68: 293-302.
3. Butterworth JF, Hines RL, Royster RL, James RL. A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery. Anesth Analg 1995; 81: 783-92.
4. Yamada T, Takeda J, Katori N, Tsuzaki K, Ochiai R. Comparison of the hemodynamic effects of milrinone for weaning from cardiopulmonary bypass between patients with a low and high pre-bypass cardiac index. J Cardiothorac Vasc Anesth 2000; 14: 367-73.
5. Feneck RO. Milrinone and postoperative pulmonary hypertension. J Cardiothorac Vasc Anesth 1993; 7: 21-3.
6. Ther Res 1999; 20: 3057-61.
7. Pamboukian SV, Carere RG, Webb JG, Cook RC, D'yachkova Y, Abel JG, et al. The use of milrinone in pre-transplant assessment of patients with congestive heart failure and pulmonary hypertension. J Heart Lung Transplant 1999; 18: 367-71.
8. Crawford MH, Souchek J, Oprian CA, Miller DC, Rahimtoola S, Giacomini JC, et al. Determinants of survival and left ventricular performance after mitral valve replacement. Circulation 1990; 81: 1173-81.